Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer

Neoplasma

Volumn 62, Issue 4, 2015, Pages 592-601

  Feng, X ^a   Song, Q ^a   Yu, A ^a   Tang, H ^b   Peng, Z ^b   Wang, X ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Colorectal cancer (CRC); Novel prognostic indicator; Receptor interacting protein kinase 3 (RIP3)

Indexed keywords

RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA EXTRACTION; SURVIVAL PREDICTION; TISSUE MICROARRAY; WESTERN BLOTTING;

EID: 84943616850     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2015_071     Document Type: Article

References (30)

1. SIEGEL R, DESANTIS C, JEMAL A. Colorectal cancer statistics, 2014. CA: a cancer journal for clinicians 2014; 64: 104–117. http://dx.doi.org/10.3322/caac.21220
2. SJOBLOM T, JONES S, WOOD LD, PARSONS DW, LIN J, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268–274. http://dx.doi.org/10.1126/science.1133427
3. GOEL A, BOLAND CR. Recent insights into the pathogenesis of colorectal cancer. Current opinion in gastroenterology 2010; 26: 47–52. http://dx.doi.org/10.1097/MOG.0b013e328332b850
4. YAN DW, LI DW, YANG YX, XIA J, WANG XL, et al. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery. British journal of cancer 2010; 103: 961–969. http://dx.doi.org/10.1038/sj.bjc.6605870
5. CHANG A. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung cancer 2011; 71: 3–10. http://dx.doi.org/10.1016/j.lungcan.2010.08.022
6. CATENACCI DV, KOZLOFF M, KINDLER HL, POLITE B. Personalized colon cancer care in 2010. Seminars in oncology 2011; 38: 284–308. http://dx.doi.org/10.1053/j.seminoncol.2011.01.001
7. SHAO L, CUI Y, LI H, LIU Y, ZHAO H, et al. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clinical cancer research: an official journal of the American Association for Cancer Research 2007; 13: 5756–5762. http://dx.doi.org/10.1158/1078-0432.CCR-06-3082
8. SIHN CR, LEE YS, JEONG JS, PARK K, KIM SH. CANu1, a novel nucleolar protein, accumulated on centromere in response to DNA damage. Genes to cells: devoted to molecular & cellular mechanisms 2008; 13: 787–796. http://dx.doi.org/10.1111/j.1365-2443.2008.01205.x
9. PRASAD RB, HOSKING FJ, VIJAYAKRISHNAN J, PAPAEMMANUIL E, KOEHLER R, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010; 115: 1765–1767. http://dx.doi.org/10.1182/blood-2009-09-241513
10. SUN X, LEE J, NAVAS T, BALDWIN DT, STEWART TA, et al. RIP3, a novel apoptosis-inducing kinase. J Biol Chem 1999; 274: 16871–16875. http://dx.doi.org/10.1074/jbc.274.24.16871
11. YU PW, HUANG BC, SHEN M, QUAST J, CHAN E, et al. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Current biology: CB 1999; 9: 539–542. http://dx.doi.org/10.1016/S0960-9822(99)80239-5
12. KASOF GM, PROSSER JC, LIU D, LORENZI MV, GOMES BC. The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria. FEBS letters 2000; 473: 285–291. http://dx.doi.org/10.1016/S0014-5793(00)01473-3
13. DECLERCQ W, VANDEN BERGHE T, VANDENABEELE P. RIP kinases at the crossroads of cell death and survival. Cell 2009; 138: 229–232. http://dx.doi.org/10.1016/j.cell.2009.07.006
14. Coupien I, Fettweis G, Piette J. RIP3 expression induces a death profile change in U2OS osteosarcoma cells after 5-ALA-PDT. Lasers in surgery and medicine 2011; 43: 557–564.
15. COUPIENNE I, FETTWEIS G, RUBIO N, AGOSTINIS P, PIETTE J. 5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma. Photochemical & photobiological sciences: Official journal of the European Photochemistry Association and the European Society for Photobiology 2011; 10: 1868–1878. http://dx.doi.org/10.1039/c1pp05213f
16. LIU P, XU B, SHEN W, ZHU H, WU W, et al. Dysregulation of TNFalpha-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1. Leukemia 2012; 26: 1293–1300. http://dx.doi.org/10.1038/leu.2011.357
17. VUCUR M, REISINGER F, GAUTHERON J, JANSSEN J, RODERBURG C, et al. RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell reports 2013; 4: 776–790. http://dx.doi.org/10.1016/j.celrep.2013.07.035
18. FENG S, MA L, YANG Y, WU M. Truncated RIP3 (tRIP3) acts upstream of FADD to induce apoptosis in the human hepatocellular carcinoma cell line QGY-7703. Biochem Biophys Res Commun 2006; 347: 558–565. http://dx.doi.org/10.1016/j.bbrc.2006.06.118
19. Pazdernikazdernik NJ, DONNER DB, GOEBL MG, HARRINGTON MA. Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB. Molecular and cellular biology 1999; 19: 6500–6508.
20. FENG S, YANG Y, MEI Y, MA L, ZHU DE, et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cellular signalling 2007; 19: 2056–2067. http://dx.doi.org/10.1016/j.cellsig.2007.05.016
21. YANG Y, MA J, CHEN Y, WU M. Nucleocytoplasmic shuttling of receptor-interacting protein 3 (RIP3): identification of novel nuclear export and import signals in RIP3. J Biol Chem 2004; 279: 38820–38829. http://dx.doi.org/10.1074/jbc.M401663200
22. ROSINAR-BESFELD R, CLIFFE A, BRABLETZ T, BIENZ M. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. The EMBO journal 2003; 22: 1101–1113. http://dx.doi.org/10.1093/emboj/cdg105
23. NIE L, SASAKI M, MAKI CG. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination. J Biol Chem 2007; 282: 14616–14625. http://dx.doi.org/10.1074/jbc.M610515200
24. KARIN M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431–436. http://dx.doi.org/10.1038/nature04870
25. SUN X, YIN J, STAROVASNIK MA, FAIRBROTHER WJ, DIXIT VM. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 2002; 277: 9505–9511. http://dx.doi.org/10.1074/jbc.M109488200
26. VAN HERREWEGHE F, FESTJENS N, DECLERCQ W, VANDENABEELE P. Tumor necrosis factor-mediated cell death: to break or to burst, that‘s the question. Cellular and molecular life sciences: CMLS 2010; 67: 1567–1579. http://dx.doi.org/10.1007/s00018-010-0283-0
27. GRETEN FR, WEBER CK, GRETEN TF, SCHNEIDER G, WAGNER M, et al. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 2002; 123: 2052–2063. http://dx.doi.org/10.1053/gast.2002.37075
28. CHO YS, CHALLA S, MOQUIN D, GENGA R, RAY TD, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137: 1112–1123. http://dx.doi.org/10.1016/j.cell.2009.05.037
29. HE S, WANG L, MIAO L, WANG T, DU F, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100–1111. http://dx.doi.org/10.1016/j.cell.2009.05.021
30. ZHANG DW, SHAO J, LIN J, ZHANG N, LU BJ, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325: 332–336. http://dx.doi.org/10.1126/science.1172308